-
Boc-Leu-Gly-Arg-PNA CAS:68223-96-1
Boc-Leu-Gly-Arg-PNA is a peptide nucleic acid (PNA) analog used in molecular biology. This compound features a backbone of pseudopeptide bonds, mimicking DNA or RNA sequences for research applications. The “Boc” group refers to a protective chemical group, while Leu, Gly, and Arg are amino acids that contribute to the peptide’s function. This PNA derivative is utilized in genetic research due to its stability and ability to bind specifically to complementary nucleic acid sequences.
-
Lanreotide CAS:108736-35-2
Lanreotide is a somatostatin drug that inhibits the secretion of a variety of hormones by mimicking the effects of natural somatostatin for the treatment of neuroendocrine tumors and related endocrine disorders.
-
Exenatide CAS:141732-76-5
Exenatide is a medication used to treat type 2 diabetes. It belongs to a class of drugs called glucagon-like peptide-1 (GLP-1) receptor agonists, which help lower blood sugar levels by increasing insulin secretion and reducing glucagon release after meals. Exenatide is administered via subcutaneous injection and is often prescribed as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes.
-
Tirzepatide CAS:2023788-19-2
Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist used in the treatment of type 2 diabetes. It works to regulate blood sugar levels by stimulating insulin release and inhibiting glucagon secretion, improving overall glycemic control. Tirzepatide is administered via subcutaneous injection and is typically prescribed alongside lifestyle modifications to help patients with type 2 diabetes achieve better control of their blood sugar levels.
-
Thymopentin CAS:69558-55-0
Thymopentin is an immunomodulatory peptide that acts on the immune system by mimicking part of the sequence of thymosin. It helps regulate T lymphocyte function and promotes immune response.
-
Pramlintide CAS:151126-32-8
Pramlintide is a synthetic form of amylin, a hormone secreted by the pancreas along with insulin to help regulate blood sugar levels. It is used in combination with insulin therapy to improve blood sugar control in patients with type 1 or type 2 diabetes.
-
Lixisenatide CAS:320367-13-3
Lixisenatide is a glucagon-like peptide-1 (GLP-1) receptor agonist used to manage blood sugar levels in patients with type 2 diabetes. It works by stimulating insulin secretion and inhibiting glucagon release, leading to improved glucose control. Lixisenatide is administered via subcutaneous injection once daily and is often prescribed alongside diet and exercise to achieve better glycemic management.
-
Octreotide CAS:79517-01-4
Octreotide is a somatostatin analogue that inhibits the secretion of multiple hormones by mimicking the effects of natural somatostatin for the treatment of neuroendocrine tumors and related endocrine disorders.
-
Liraglutide CAS:204656-20-2
Liraglutide is a GLP-1 receptor agonist used to treat type 2 diabetes and obesity. It mimics the action of GLP-1 by promoting insulin secretion and inhibiting the release of glucagon, helping to lower blood sugar levels and weight.
-
Teduglutide CAS:197922-42-2
Teduglutide is a drug used to treat short bowel syndrome (SBS), a rare condition that can occur after surgical removal of a portion of the small intestine. This drug is a synthetic form of a naturally occurring hormone called glucagon-like peptide-2 (GLP-2), which helps to improve intestinal absorption and reduce the need for parenteral nutrition in patients with SBS.
-
Pasireotide CAS:396091-73-9
Pasireotide is a multi-receptor targeted drug used to treat specific types of endocrine disorders and related diseases by inhibiting the activity of multiple growth hormone and insulin-like growth factor receptors.
-
Mifamurtide CAS:83461-56-7
Mifamurtide is an immunomodulator that acts as a lipopolysaccharide drug to fight tumors by mimicking and enhancing the host’s immune response.
